Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXELON CORP | 17,255 | reported | 24 Feb 2014 | tx 39+516,088−52,447 |
| CONSTELLATION ENERGY GROUP INC | 0 | reported | 12 Mar 2012 | tx 61+732,863−523,515.91 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2014 | TAX_WITHHOLDING | EXELON CORP | 1,398 | 30.39 USD | |
| 24 Feb 2014 | EXERCISE | EXELON CORP | 3,486 | 30.39 USD | |
| 24 Feb 2014 | EXERCISE | EXELON CORP | 3,486 | 30.39 USD | |
| 27 Jan 2014 | TAX_WITHHOLDING | EXELON CORP | 3,623 | 28.20 USD | |
| 27 Jan 2014 | OTHER | EXELON CORP | 3,466 | 28.20 USD | |
| 27 Jan 2014 | EXERCISE | EXELON CORP | 2,957 | 28.20 USD | |
| 27 Jan 2014 | EXERCISE | EXELON CORP | 9,740 | 28.20 USD | |
| 27 Jan 2014 | GRANT_AWARD | EXELON CORP | 9,600 | 0.00 USD | deriv |
| 27 Jan 2014 | EXERCISE | EXELON CORP | 2,957 | 28.20 USD | deriv |
| 27 Jan 2014 | GRANT_AWARD | EXELON CORP | 4,324 | 0.00 USD | deriv |
| 27 Jan 2014 | EXERCISE | EXELON CORP | 9,740 | 28.20 USD | deriv |
| 06 May 2013 | GIFT | EXELON CORP | 2,792 | 0.00 USD | |
| 11 Mar 2013 | GIFT | EXELON CORP | 2,130 | 0.00 USD | |
| 11 Mar 2013 | GIFT | EXELON CORP | 2,130 | 0.00 USD | |
| 24 Feb 2013 | TAX_WITHHOLDING | EXELON CORP | 1,196 | 30.49 USD | |
| 24 Feb 2013 | EXERCISE | EXELON CORP | 3,326 | 30.49 USD | |
| 24 Feb 2013 | EXERCISE | EXELON CORP | 3,326 | 30.49 USD | |
| 06 Feb 2013 | GIFT | EXELON CORP | 1,738 | 0.00 USD | |
| 06 Feb 2013 | GIFT | EXELON CORP | 1,738 | 0.00 USD | |
| 28 Jan 2013 | OTHER | EXELON CORP | 1,739 | 31.18 USD | |
| 28 Jan 2013 | TAX_WITHHOLDING | EXELON CORP | 1,939 | 31.18 USD | |
| 28 Jan 2013 | EXERCISE | EXELON CORP | 5,417 | 31.18 USD | |
| 28 Jan 2013 | GRANT_AWARD | EXELON CORP | 8,300 | 31.18 USD | deriv |
| 28 Jan 2013 | GRANT_AWARD | EXELON CORP | 16,250 | 31.18 USD | deriv |
| 28 Jan 2013 | EXERCISE | EXELON CORP | 5,417 | 31.18 USD | deriv |